Please login to the form below
Trobalt
This page shows the latest Trobalt news and features for those working in and with pharma, biotech and healthcare.
GSK/ Valeant's Trobalt set for EU restrictions
European regulatory advisors have recommended GlaxoSmithKline and Valeant's epilepsy drug Trobalt be restricted after safety concerns over its use emerged. ... The CHMP said the move followed cases of abnormal colouring of the skin, nails, lips and eye
Latest news
-
Therapy focus: Epilepsy
In May 2011, GlaxoSmithKline launched its new epilepsy medicine Trobalt in the UK.
-
FDA approves GSK/Valeant anti-seizure drug
In the EU, ezogabine is known as retigabine (Trobalt). The drug received marketing authorisation in the EU in March 2011.
-
GSK launches first-in-class epilepsy drug
GSK introduces Trobalt for the adjunct treatment of adults with partial-onset seizures. ... GlaxoSmithKline (GSK) has launched Trobalt (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with
-
GSK sales fall for first quarter of 2011
Recent approvals for GSK include lupus drug Benlysta (belimumab), Horizant (gabapentin enacarbil) for Restless Legs Syndrome and epilepsy treatment Trobalt (retigabine).
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Country report: The healthcare market in Germany
Committee and the same 'no proof' decision was reached regarding GlaxoSmithKline's Trobalt (retigabine) for epilepsy.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Manager / Account Director
-
Competative
-
Associate Director
-
£75, 000-90, 000
-
Senior Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Novartis forges AI alliance with Oxford University
- J&J earnings top expectations, but feels the squeeze in US
- Researchers reverse Alzheimer’s memory loss in mice
- Editas CEO exits the CRISPR firm ahead of first clinical trial
- A dynamic and challenging environment – what it’s like starting a career in MedComms
- UniQure cleared to start Huntington gene therapy trial
- HSJ Partnership Awards 2019 shortlist announced
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
